基于纳米生物技术在肿瘤中的研究现状
Current Status of Nanobiotechnology-Based Research in Cancer
DOI: 10.12677/acm.2024.1471996, PDF,   
作者: 秦季秋*, 熊绍权#：成都中医药大学，临床医学院，四川 成都；刘彦君：泸州市纳溪区中医医院，针灸康复科，四川 泸州
关键词: 纳米生物技术；恶性肿瘤；诊疗技术；研究现状；Nanobiotechnology； Cancer； Treatment Technology； Research Status
摘要: 早发现、早诊断、早治疗是恶性肿瘤诊疗的关键。恶性肿瘤诊疗技术朝着原子、分子等方向发展，肿瘤患者生存期延长、生活质量提高，但对于恶性肿瘤的诊疗仍在积极探索新的道路。而纳米生物技术的出现，为恶性肿瘤的诊断及治疗提供新的方法及手段，其具有高灵敏度、特异性等，因此利用其特性用于药物递送、分子成像等方面诊疗恶性肿瘤。本文就药物递送、分子成像及生物标志物图谱、调控肿瘤微环境等方面论述纳米生物技术在恶性肿瘤中的进展，并展望其对恶性肿瘤诊疗的临床应用的挑战。
Abstract: Early detection, early diagnosis and early treatment are the keys to cancer diagnosis and treatment. The development of cancer treatment technology towards atomic and molecular directions has prolonged the survival period and improved the quality of life of tumor patients, but the treatment of malignant tumors is still actively exploring new paths. The emergence of nanobiotechnology has provided new methods and means for the diagnosis and treatment of malignant tumors, and with its high sensitivity and specificity, its characteristics are used for drug delivery and molecular imaging to treat malignant tumors. This paper discusses the progress of nanobiotechnology in malignant tumors in terms of drug delivery, molecular imaging, and biomarker mapping, and regulation of tumor microenvironment, and looks forward to the challenges of its clinical application for malignant tumor diagnosis and treatment.
文章引用：秦季秋, 刘彦君, 熊绍权. 基于纳米生物技术在肿瘤中的研究现状[J]. 临床医学进展, 2024, 14(7): 165-171. https://doi.org/10.12677/acm.2024.1471996

参考文献

[1] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[2] Kohler, B.A., Sherman, R.L., Howlader, N., Jemal, A., Ryerson, A.B., Henry, K.A., et al. (2015) Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State. Journal of the National Cancer Institute, 107, djv048. [Google Scholar] [CrossRef] [PubMed]
[3] Henley, S.J., Thomas, C.C., Lewis, D.R., Ward, E.M., Islami, F., Wu, M., et al. (2020) Annual Report to the Nation on the Status of Cancer, Part II: Progress toward Healthy People 2020 Objectives for 4 Common Cancers. Cancer, 126, 2250-2266. [Google Scholar] [CrossRef] [PubMed]
[4] Crosby, D., Bhatia, S., Brindle, K.M., Coussens, L.M., Dive, C., Emberton, M., et al. (2022) Early Detection of Cancer. Science, 375, eaay9040. [Google Scholar] [CrossRef] [PubMed]
[5] Zhang, Y., Wang, Y., Zhang, B., Li, P. and Zhao, Y. (2023) Methods and Biomarkers for Early Detection, Prediction, and Diagnosis of Colorectal Cancer. Biomedicine & Pharmacotherapy, 163, Article 114786. [Google Scholar] [CrossRef] [PubMed]
[6] 中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2021年版) [J]. 中国癌症杂志, 2021, 31(10): 954-1040.
[7] 杨芳, 童杨, 顾宁. 纳米生物材料的研究进展与发展趋势[J]. 中国基础科学, 2022, 24(1): 46-56.
[8] Jin, X., Demere, Z., Nair, K., Ali, A., Ferraro, G.B., Natoli, T., et al. (2020) A Metastasis Map of Human Cancer Cell Lines. Nature, 588, 331-336. [Google Scholar] [CrossRef] [PubMed]
[9] Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. [Google Scholar] [CrossRef] [PubMed]
[10] Hu, J., Huang, W., Huang, S., ZhuGe, Q., Jin, K. and Zhao, Y. (2016) Magnetically Active Fe3O4 Nanorods Loaded with Tissue Plasminogen Activator for Enhanced Thrombolysis. Nano Research, 9, 2652-2661. [Google Scholar] [CrossRef] 
[11] Blanco, E., Shen, H. and Ferrari, M. (2015) Principles of Nanoparticle Design for Overcoming Biological Barriers to Drug Delivery. Nature Biotechnology, 33, 941-951. [Google Scholar] [CrossRef] [PubMed]
[12] Mohammadi-Samani, S. and Ghasemiyeh, P. (2018) Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Novel Drug Delivery Systems: Applications, Advantages and Disadvantages. Research in Pharmaceutical Sciences, 13, 288-303. [Google Scholar] [CrossRef] [PubMed]
[13] Goldberg, M.S. (2015) Immunoengineering: How Nanotechnology Can Enhance Cancer Immunotherapy. Cell, 161, 201-204. [Google Scholar] [CrossRef] [PubMed]
[14] 徐寅生, 任翔宇, 余梦真, 等. 基于纳米技术的药物递送策略及其在癌症治疗中的应用[J]. 科学通报, 2023, 68(32): 4346-4372.
[15] Wang, H., Zheng, M., Gao, J., Wang, J., Zhang, Q., Fawcett, J.P., et al. (2020) Uptake and Release Profiles of Pegylated Liposomal Doxorubicin Nanoparticles: A Comprehensive Picture Based on Separate Determination of Encapsulated and Total Drug Concentrations in Tissues of Tumor-Bearing Mice. Talanta, 208, Article 120358. [Google Scholar] [CrossRef] [PubMed]
[16] Li, Y., Yin, C., Li, X., Liu, B., Wang, J., Zheng, X., et al. (2019) Electroacupuncture Alleviates Paclitaxel-Induced Peripheral Neuropathic Pain in Rats via Suppressing TLR4 Signaling and TRPV1 Upregulation in Sensory Neurons. International Journal of Molecular Sciences, 20, Article 5917. [Google Scholar] [CrossRef] [PubMed]
[17] Kaushik, N., Borkar, S.B., Nandanwar, S.K., Panda, P.K., Choi, E.H. and Kaushik, N.K. (2022) Nanocarrier Cancer Therapeutics with Functional Stimuli-Responsive Mechanisms. Journal of Nanobiotechnology, 20, Article No. 152. [Google Scholar] [CrossRef] [PubMed]
[18] 黎犇犇, 王俊潇, 许娅. 白蛋白紫杉醇对比多西他赛在三阴性乳腺癌新辅助治疗中的疗效分析[J]. 中外医疗, 2022, 41(11): 76-79.
[19] 单海霞. 白蛋白结合型紫杉醇在晚期乳腺癌治疗中的疗效及安全性分析[J]. 医学信息, 2022, 35(3): 165-167.
[20] Bencsik, A. and Lestaevel, P. (2021) The Challenges of 21st Century Neurotoxicology: The Case of Neurotoxicology Applied to Nanomaterials. Frontiers in Toxicology, 3, Article 629256. [Google Scholar] [CrossRef] [PubMed]
[21] Lv, W., Liu, Y., Li, S., Lv, L., Lu, H. and Xin, H. (2022) Advances of Nano Drug Delivery System for the Theranostics of Ischemic Stroke. Journal of Nanobiotechnology, 20, Article No. 248. [Google Scholar] [CrossRef] [PubMed]
[22] Sathish Sundar, D., Gover Antoniraj, M., Senthil Kumar, C., S. Mohapatra, S., N. Houreld, N. and Ruckmani, K. (2016) Recent Trends of Biocompatible and Biodegradable Nanoparticles in Drug Delivery: A Review. Current Medicinal Chemistry, 23, 3730-3751. [Google Scholar] [CrossRef] [PubMed]
[23] Panzarini, E., Mariano, S., Carata, E., Mura, F., Rossi, M. and Dini, L. (2018) Intracellular Transport of Silver and Gold Nanoparticles and Biological Responses: An Update. International Journal of Molecular Sciences, 19, Article 1305. [Google Scholar] [CrossRef] [PubMed]
[24] Bonferoni, M.C., Rassu, G., Gavini, E., Sorrenti, M., Catenacci, L., Torre, M.L., et al. (2021) Electrochemotherapy of Deep-Seated Tumors: State of Art and Perspectives as Possible “EPR Effect Enhancer” to Improve Cancer Nanomedicine Efficacy. Cancers, 13, Article 4437. [Google Scholar] [CrossRef] [PubMed]
[25] 谭广, 李卉. 靶向性超顺磁性氧化铁纳米颗粒早期诊断胰腺癌的研究进展[J]. 医学综述, 2020, 26(9): 1725-1729, 1734.
[26] Jafari, A., Salouti, M., Shayesteh, S.F., Heidari, Z., Rajabi, A.B., Boustani, K., et al. (2015) Synthesis and Characterization of Bombesin-Superparamagnetic Iron Oxide Nanoparticles as a Targeted Contrast Agent for Imaging of Breast Cancer Using MRI. Nanotechnology, 26, Article 075101. [Google Scholar] [CrossRef] [PubMed]
[27] Chakraborty, S., Peruncheralathan, S. and Ghosh, A. (2021) Paracetamol and Other Acetanilide Analogs as Inter-Molecular Hydrogen Bonding Assisted Diamagnetic CEST MRI Contrast Agents. RSC Advances, 11, 6526-6534. [Google Scholar] [CrossRef] [PubMed]
[28] Garrigue, P., Tang, J., Ding, L., Bouhlel, A., Tintaru, A., Laurini, E., et al. (2018) Self-Assembling Supramolecular Dendrimer Nanosystem for PET Imaging of Tumors. Proceedings of the National Academy of Sciences, 115, 11454-11459. [Google Scholar] [CrossRef] [PubMed]
[29] Li, W., Yu, H., Ding, D., Chen, Z., Wang, Y., Wang, S., et al. (2019) Cold Atmospheric Plasma and Iron Oxide-Based Magnetic Nanoparticles for Synergetic Lung Cancer Therapy. Free Radical Biology and Medicine, 130, 71-81. [Google Scholar] [CrossRef] [PubMed]
[30] Lyu, Z., Ding, L., Tintaru, A. and Peng, L. (2020) Self-Assembling Supramolecular Dendrimers for Biomedical Applications: Lessons Learned from Poly (Amidoamine) Dendrimers. Accounts of Chemical Research, 53, 2936-2949. [Google Scholar] [CrossRef] [PubMed]
[31] Orozco-Barocio, A., Robles-Rodríguez, B.S., Camacho-Corona, M.d.R., Méndez-López, L.F., Godínez-Rubí, M., Peregrina-Sandoval, J., et al. (2022) In vitro Anticancer Activity of the Polar Fraction from the Lophocereus schottii Ethanolic Extract. Frontiers in Pharmacology, 13, Article 820381. [Google Scholar] [CrossRef] [PubMed]
[32] 鄢少聪, 应学明, 赵建华, 等. 循环肿瘤细胞及磷酸酶张力蛋白同源物基因检测在III期结直肠癌中的临床意义[J]. 癌症进展, 2021, 19(15): 1536-1541.
[33] Jiang, L., Lin, X., Chen, F., Qin, X., Yan, Y., Ren, L., et al. (2023) Current Research Status of Tumor Cell Biomarker Detection. Microsystems & Nanoengineering, 9, Article No. 123. [Google Scholar] [CrossRef] [PubMed]
[34] Dholariya, S., Gupta, R., Radadiya, M. and Agarwal, P. (2022) NGAL/MMP-9 as a Biomarker for Epithelial Ovarian Cancer: A Case-Control Diagnostic Accuracy Study. Saudi Journal of Medicine and Medical Sciences, 10, 25-30. [Google Scholar] [CrossRef] [PubMed]
[35] Geho, D., Jones, C., Petricoin, E. and Liotta, L. (2006) Nanoparticles: Potential Biomarker Harvesters. Current Opinion in Chemical Biology, 10, 56-61. [Google Scholar] [CrossRef] [PubMed]
[36] Luchini, A., Fredolini, C., Espina, B., Meani, F., Reeder, A., Rucker, S., et al. (2010) Nanoparticle Technology: Addressing the Fundamental Roadblocks to Protein Biomarker Discovery. Current Molecular Medicine, 10, 133-141. [Google Scholar] [CrossRef] [PubMed]
[37] Roverso, M., Seraglia, R., Dogra, R., Badocco, D., Pettenuzzo, S., Cappellin, L., et al. (2022) Single-Walled Carbon Nanohorns as Boosting Surface for the Analysis of Low-Molecular-Weight Compounds by SALDI-MS. International Journal of Molecular Sciences, 23, Article 5027. [Google Scholar] [CrossRef] [PubMed]
[38] 赵琪, 刘庄. 基于纳米生物材料的肿瘤乏氧调控与放疗增效研究进展[J]. 肿瘤防治研究, 2021, 48(2): 109-114.
[39] 邸士鸣, 龚礼栋, 庄峰, 等. 超pH敏感荧光纳米探针的pH转变点对其肿瘤成像效果的影响[J]. 药学学报, 2022, 57(1): 169-177, 278.

为你推荐